Skip to main navigation Skip to search Skip to main content

The value of exhaled nitric oxide to identify asthma in smoking patients with asthma-like symptoms

Andrei Malinovschi, Vibeke Backer, Henrik Harving, Celeste Porsbjerg

42 Citations (Scopus)

Abstract

The fraction of nitric oxide in exhaled air (FeNO) is used in asthma diagnosis and management. Smoking reduces FeNO and 20-35% of asthmatics are smoking. However no guidelines exist on the diagnostic value of FeNO in smokers. Therefore we assessed the value of FeNO to diagnose asthma in a population of subjects with asthma-like symptoms and different smoking habits.
Original languageEnglish
JournalRespiratory medicine
Volume106
Issue number6
Pages (from-to)794-801
Number of pages8
ISSN0954-6111
DOIs
Publication statusPublished - 2012

Keywords

  • Adolescent
  • Adult
  • Asthma
  • Biological Markers
  • Breath Tests
  • Bronchial Hyperreactivity
  • Diagnosis, Differential
  • Eosinophils
  • Female
  • Forced Expiratory Volume
  • Humans
  • Hypersensitivity, Immediate
  • Leukocyte Count
  • Male
  • Nitric Oxide
  • Smoking
  • Smoking Cessation
  • Vital Capacity
  • Young Adult

Fingerprint

Dive into the research topics of 'The value of exhaled nitric oxide to identify asthma in smoking patients with asthma-like symptoms'. Together they form a unique fingerprint.

Cite this